Skip to content
10-Q

Quarterly Report

LifeStance Health Group, Inc. LFST

0000950170-25-065806

← back to feed
Filed
May 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 30, 2025 388.88M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $276.32M
Long Term Debt Q1 2025 · Dec 31, 2024 $279.79M
Short Term Debt Q1 2025 · Mar 31, 2025 $9.06M
Short Term Debt Q1 2025 · Dec 31, 2024 $7.25M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $134.34M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $154.57M
Stockholders Equity Q1 2025 · Mar 31, 2025 $1.46B
Stockholders Equity Q1 2025 · Dec 31, 2024 $1.45B
Current Liabilities Q1 2025 · Mar 31, 2025 $207.39M
Current Liabilities Q1 2025 · Dec 31, 2024 $228.89M
Total Liabilities Q1 2025 · Mar 31, 2025 $647.57M
Total Liabilities Q1 2025 · Dec 31, 2024 $672.01M
Current Assets Q1 2025 · Mar 31, 2025 $304.63M
Current Assets Q1 2025 · Dec 31, 2024 $312.51M
Total Assets Q1 2025 · Mar 31, 2025 $2.1B
Total Assets Q1 2025 · Dec 31, 2024 $2.12B
Shares Diluted Q1 2025 · Mar 31, 2024 376.33M sh
Capex Q1 2025 · Mar 31, 2024 $5.1M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$21.84M
Sga Expense Q1 2025 · Mar 31, 2024 $88.93M
Net Income Q1 2025 · Mar 31, 2024 −$21.1M
Operating Income Q1 2025 · Mar 31, 2024 −$16.77M